Search for: "DAIICHI SANKYO CO., LTD"
Results 41 - 60
of 60
Sorted by Relevance
|
Sort by Date
1 Apr 2016, 8:22 am
Petitions for Writ of Certiorari Denied or Dismissed: Daiichi Sankyo Company, Ltd. v. [read post]
8 Dec 2010, 2:20 am
: Daiichi Sankyo Co Ltd v Comptroller General of Patents (The SPC Blog) Coversyl (Perindopril) – Australia: FCAFC: Servier denied patent amendment on appeal: Les Laboratoires Servier v Apotex (Patentology) Prandin (Repaglinide) – US: Paddock fails to dismiss Novo’s Prandin patent suit (Patent Docs) Spiriva (Tiotropium bromide monohydrate) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Temodar… [read post]
3 Feb 2016, 8:57 am
”) Patent Term Adjustment Dispute: Daiichi Sankyo Company, Ltd. v. [read post]
10 Aug 2010, 8:44 pm
General Coverage of anti-counterfeit policy debate varies widely across global media (IP Watch) WHO declares flu pandemic over; experts behind response to be revealed (IP Watch) Australia: TGA to implement alert system for new ARTG registrations (IP Whiteboard) EU: Final petition of the Advocate-General / Jodosulfuron- SPC for plant protection products (EPLAW) India: Parliamentary Committee on Health tables report on issues relating to availability of generic medicines (Spicy IP) Peru:… [read post]
14 Dec 2015, 9:43 am
”) Patent Term Adjustment Dispute: Daiichi Sankyo Company, Ltd. v. [read post]
3 May 2016, 1:42 am
MPHJ Technology Investments, LLC, No. 15-838 (Federal court jurisdiction in anti-troll consumer protection case) Daiichi Sankyo Company, Ltd. v. [read post]
7 Dec 2015, 6:08 am
”) Daiichi Sankyo Company, Ltd. v. [read post]
8 Dec 2010, 1:49 am
In this episode Cautious Co learns how to issue proceedings. [read post]
3 Jun 2016, 6:40 am
MPHJ Technology Investments, LLC, No. 15-838 (Federal court jurisdiction in anti-troll consumer protection case) Daiichi Sankyo Company, Ltd. v. [read post]
18 Apr 2016, 9:58 am
MPHJ Technology Investments, LLC, No. 15-838 (Federal court jurisdiction in anti-troll consumer protection case) Daiichi Sankyo Company, Ltd. v. [read post]
18 May 2016, 8:19 am
MPHJ Technology Investments, LLC, No. 15-838 (Federal court jurisdiction in anti-troll consumer protection case) Daiichi Sankyo Company, Ltd. v. [read post]
17 Mar 2016, 2:45 am
Jack Henry & Associates, Inc., No. 15-974 (defining an abstract idea) Patent Term Adjustment Dispute: Daiichi Sankyo Company, Ltd. v. [read post]
28 Jun 2016, 6:41 am
SAP, No. 15-1145 (scope of CBM review) Samsung Electronics Co., Ltd., et al. v. [read post]
18 Jul 2008, 8:34 am
: (GenericsWeb), Eularis analyses most effective generics defence strategies with new pharmaceutical industry report: (GenericsWeb), WIPO symposium to discuss life sciences multilateral environmental agreements: (Daily Dose of IP), Daiichi Sankyo and Ranbaxy confirm deal is binding and final, allay market rumour and speculation: (SmartBrief), Daiichi Ranbaxy takeover and the implications for the future of IP: (Spicy IP), Europe: Cancer Research Therapeutics’ RNAi… [read post]
11 Jul 2008, 4:30 am
: (Spicy IP), India: Ranbaxy-Daiichi deal – Opportunities for private equity companies in India: (Profitability through Simplicity), India: (KEI) Cracking open anti-competitive practices in the developing world: complaints, amendments and waivers: (Spicy IP), India: Is it one rule for Indian pharma companies and another one for those from abroad? [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb), EU: Pharmaceutical sector enquiry regarding possible misuse of IP rights: (GenericsWeb), India: Indian government seeks to be a leader in deep sea bed mining to provide competitive edge for pharmaceutical companies in the development of new drugs: (Spicy IP),India : Medical Devices Regulation Bill formulated: (Spicy IP),India : Pharma gets bigger - Novo Nordisk and Merck & Co expansion plans: (Spicy IP),India : US patent reform and the Indian generics market:… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to… [read post]
20 Jun 2008, 8:07 am
– Marks & Clerk Biotechnology Report 2008: (IP finance), Pfizer and Daiichi-Sankyo’s bidding for Ranbaxy: (IP ThinkTank), (IAM), (Managing Intellectual Property), (GenericsWeb), Cutting Edge Information study reveals 53% of pharma patents approach expiration before litigation strategies are implemented: (Peter Zura's 271 Patent Blog), Quanta and agricultural biotechnology: (Holman’s Biotech IP Blog), Breakthough by WHO will give poor… [read post]
6 Jun 2008, 6:49 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
6 Dec 2016, 8:11 am
The blood thinning drug Xarelto has alarming side effects, the most dangerous of which is uncontrollable internal bleeding. [read post]
